US SB4698 | 2025-2026 | 119th Congress
Status
Sponsorship: Partisan Bill (Republican 2)
Status: Introduced on June 8 2026 - 25% progression
Action: 2026-06-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Status: Introduced on June 8 2026 - 25% progression
Action: 2026-06-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
Title
A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
Sponsors
| Sen. Ron Johnson [R-WI] | Sen. Tommy Tuberville [R-AL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2026-06-08 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/senate-bill/4698/all-info |
